Evidence map›Paper›PMID 41855971›Full record

ArticleEBioMedicine2026

Clonal dynamics of HIV-infected and uninfected T cells.

Samuel Weissman, Ashley M Ginda, Alfonso Oceguera, Liam Swiggard, Marilia Pinzone, LaMont Cannon, Ryan Zurakowski, Stephen Migueles, Frederic D Bushman, Una O'Doherty

Abstract read
In one paragraph

Article in EBioMedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Samuel WeissmanDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Ashley M GindaDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, 30322, USA.
Alfonso OcegueraDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, 30322, USA.
Liam SwiggardDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Marilia PinzoneDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
LaMont CannonDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA; Center for the Study of Biological Complexity, Virginia Commonwealth University, Richmond, VA, 23284, USA.
Ryan ZurakowskiDepartment of Biomedical Engineering, University of Delaware, Newark, DE, 19716, USA.
Stephen MiguelesThe Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.
Frederic D BushmanDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, 19104, PA, USA.
Una O'DohertyDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, 30322, USA. Electronic address: una.odoherty@emory.edu.

Funding

The barcode project: a strategy to track the early naïve reservoirR01AI176952 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Una T O'Doherty · 2023 to 2026
$3.2M
Training Grant in Transfusion Medicine (T32)T32HL069769 · NHLBI · EMORY UNIVERSITY · PI Una T O'Doherty, John D Roback · 2004 to 2026
$2.6M
NHLBI NIH HHS T32 HL069769NIAID NIH HHS R01 AI176952
6 · The paper itself

Abstract

backgroundThe HIV reservoir was once considered to be transcriptionally silent. Evidence is emerging that a substantial portion of the reservoir is transcriptionally active. We explore the consequences of transcriptionally active proviruses on the infected T cell by longitudinally monitoring the fate of proviral clones.

methodsWe analysed proviral dynamics by monitoring ∼4000 HIV proviral sequences and ∼13,000 integration site sequences along with ∼2 million T cell receptor (TCR) sequences in up to 9 people living with HIV over time. This analysis includes 7 chronically treated and 2 elite controller participants, with paired TCR sequencing in 6 individuals. We also analysed 9 participants from published cohorts. Our analysis used a Morisita metric to capture contraction and expansion of proviral clones. The role of HIV expression was also investigated by studying the effect of integration site and orientation indirectly in vivo and directly in a cell line model.

findingsWe focus on cell-intrinsic forces and provide evidence that proviral clones contract and expand more in individuals treated during chronic infection compared to elite controllers. Moreover, proviral clones change more than TCR clones suggesting a subset of infected cells may turnover more than uninfected cells. We also provide evidence of two opposing forces, both initiated by HIV expression within the cell, likely contributing to proviral dynamics. These forces could explain the increased changes in proviral clones in a subset of infected cells. Evidence of an expansion force includes an enrichment of sense-oriented proviruses in growth-related genes among large clones. At the same time, there is depletion of sense-oriented proviruses in highly expressed genes, leading to an overall enrichment of antisense.

interpretationOur longitudinal analysis of HIV sequences suggests that a subset of HIV-infected cells may divide and die faster than uninfected T cells, contributing to a dynamic reservoir.

fundingThis work was funded by the National Institute of Allergy and Infectious Diseases, National Institutes of Health, United States (R01AI176952, R01AI165368, and R37AI150556).

Indexed as

HIV-1HIV InfectionsT-LymphocytesHumansProvirusesReceptors, Antigen, T-CellViral LoadVirus IntegrationReceptors, Antigen, T-CellHIVHIV reservoir and clonal dynamicsProviral and integration site sequencingTCR sequencingVirus-host interactions

Identifiers

PMID41855971
PMCPMC13015742

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.